ECS dysregulation, especially due to exogenous cannabinoids, may contribute to reproductive pathologies such as polycystic ovary syndrome (PCOS) [178] and is also linked to altered CB1/CB2 receptor expression in endometrial disorders [179,180]. Here, CNR1 is linked to polycystic ovary syndrome.